Recent Comments

Comment RSS

Calcium News and Research RSS Feed - Calcium News and Research

Calcium, the most abundant mineral in the body, is found in some foods, added to others, available as a dietary supplement, and present in some medicines (such as antacids). Calcium is required for muscle contraction, blood vessel expansion and contraction, secretion of hormones and enzymes, and transmitting impulses throughout the nervous system. The body strives to maintain constant concentrations of calcium in blood, muscle, and intercellular fluids, though less than <1% of total body calcium is needed to support these functions.

The remaining 99% of the body's calcium supply is stored in the bones and teeth where it supports their structure. Bone itself undergoes continuous remodeling, with constant resorption and deposition of calcium into new bone. The balance between bone resorption and deposition changes with age. Bone formation exceeds resorption in growing children, whereas in early and middle adulthood both processes are relatively equal. In aging adults, particularly among postmenopausal women, bone breakdown exceeds formation, resulting in bone loss that increases the risk of osteoporosis over time.

FDA extends Exalgo NDA review by three months

20. November 2009 08:11
CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued Neuromed a letter extending its review of the New Drug Application (NDA) for the product candidate Exalgo™ (hydromorphone HCl) extended-release tablets by three months. [More]

Posted in: Business / Finance | Pharmaceutical News

Tags: , , , , ,

Physicists observe experimental evidence for directed percolation

20. November 2009 04:44
A team of physicists has, for the first time, seen convincing experimental evidence for directed percolation, a phenomenon that turns up in computer models of the ways diseases spread through a population or how water soaks through loose soil. Their observation strengthens the case for directed percolation's relevance to real systems, and lends new vigor to long-standing theories about how it works. Their experiment is reported in Physical Review E and highlighted with a Viewpoint in the November 16 issue of Physics (http://physics.aps.org). [More]

Posted in: Device / Technology News | Disease/Infection News

Tags: ,

Schoolchildren should eat snail pie to reduce malnutrition and iron deficiency, says nutritionist

20. November 2009 02:14
A nutritionist in Nigeria says that malnutrition and iron deficiency in schoolchildren could be reduced in her country by baking up snail pie. In a research paper to be published in the International Journal of Food Safety, Nutrition and Public Health, she explains snail is not only cheaper and more readily available than beef but contains more protein. [More]

Posted in: Medical Condition News

Tags: , , , , , , ,

Cardiovascular Systems commences patient enrollment in CALCIUM 360° clinical trial

19. November 2009 08:45
Cardiovascular Systems, Inc., announces the first patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company’s 360° Clinical Series. The CALCIUM 360° study will evaluate the treatment of peripheral arterial disease (PAD) behind and below the knee using CSI’s Diamondback 360® PAD System, a minimally invasive catheter for treating PAD anywhere in the leg. [More]

Astellas Pharma and XenoPort submit NDA in Japan for PMDA approval

19. November 2009 07:06
Astellas Pharma Inc. and XenoPort, Inc. today announced that a new drug application (NDA) has been filed with the Pharmaceuticals and Medical Device Agency (PMDA) in Japan for ASP8825 (gabapentin enacarbil), also known as XP13512, as a potential treatment for restless legs syndrome (RLS). [More]

Overexpression of NCX1, do not by itself lead to contraction abnormalities in heart

19. November 2009 06:39
Researchers from the Center for Translational Medicine at Thomas Jefferson University have found that the overexpression of a sodium/calcium exchanger, without changes in other ion transport pathways commonly observed in heart failure, does not by itself lead to contraction abnormalities in the heart. [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , ,

PanGenex expands clinical trial sites of its Calci-CLEAR system

19. November 2009 06:14
PanGenex Corporation announced that due to promising pre-clinical results from its clinical trial at the Cardiovascular Institute of the South (http://www.cardio.com/site1.php), the Company will extend its trial to two additional sites. [More]

Posted in: Device / Technology News

Tags: , , ,

European market for dental implants and final abutments to reach a market value of euro 1.3 billion by 2015

18. November 2009 06:27
In 2008, the combined European market for dental implants and final abutments increased by 6.8% over 2007. [More]

Posted in: Device / Technology News

Tags: ,

CRESTOR reduces major cardiovascular events in women by 46%

18. November 2009 05:05
A new analysis of the JUPITER trial, released today at the American Heart Association meeting in Orlando, Florida, demonstrates that CRESTOR (rosuvastatin calcium) 20mg reduced first major cardiovascular events by 46%. [More]

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

17. November 2009 08:27
Cytokinetics, Incorporated announced today that three abstracts summarizing non-clinical data regarding its smooth muscle contractility program were presented at the 2009 Scientific Sessions of the American Heart Association in Orlando, Florida. [More]

Assessing the neurology market and its major players

17. November 2009 04:13
Research and Markets (http://www.researchandmarkets.com/research/63cb3f/dealmaking_and_ind) has announced the addition of Decision Resources, Inc.'s new report "Dealmaking and Industry Outlook: Neurological Disease" to their offering. [More]

Upsher-Smith Laboratories publishes results of SLIM Study

17. November 2009 04:10
Results of the SLIM Study ("Slo-Niacin® and Atorvastatin Treatment of Lipoproteins and Inflammatory Markers in Combined Hyperlipidemia") were recently published in the Journal of Clinical Lipidology. [More]

GE Healthcare announces results from ongoing evaluation of Gemstone Spectral Imaging

17. November 2009 03:58
GE Healthcare today announced results from its ongoing customer evaluation of Gemstone Spectral Imaging, a technology aiming to enhance CT’s diagnostic capability. Gemstone Spectral Imaging is an available option for Discovery CT750HD systems and is being delivered to customers worldwide. [More]

Posted in: Device / Technology News

Tags: , , , ,

FDA provides feedback on the pending NDA for EXALGO tablets

17. November 2009 03:33
CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time, with staff from the United States Food and Drug Administration (FDA). [More]

Posted in: Pharmaceutical News

Tags: , , , ,

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

17. November 2009 03:13
BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company developing products for female sexual health, including LibiGel® for the treatment of hypoactive sexual desire disorder (HSDD), applauds the efforts of Boehringer Ingelheim to develop a therapy to treat this unmet medical need. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.